|
1
|
Folkman J: Tumor angiogenesis: therapeutic
implications. N Engl J Med. 285:1182–1186. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Folkman J and Shing Y: Angiogenesis. J
Biol Chem. 267:10931–10934. 1992.
|
|
3
|
Folkman J: Angiogenesis in cancer,
vascular, rheumatoid and other diseases. Nat Med. 1:27–31. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Folkman J: Angiogenesis. Annu Rev Med.
57:1–18. 2006. View Article : Google Scholar
|
|
5
|
Cook KM and Figg WD: Angiogenesis
inhibitors: current strategies and future prospects. CA Cancer J
Clin. 60:222–243. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar
|
|
7
|
Whiteside TL: The tumor microenvironment
and its role in promoting tumor growth. Oncogene. 27:5904–5912.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jain RK: Transport of molecules in the
tumor interstitium: a review. Cancer Res. 47:3039–3051.
1987.PubMed/NCBI
|
|
9
|
Folkman J: How is blood vessel growth
regulated in normal and neoplastic tissue? GHA Clowes memorial
award lecture. Cancer Res. 46:467–473. 1986.PubMed/NCBI
|
|
10
|
Robert S and Kerbel RS: Tumor
angiogenesis. N Engl J Med. 358:2039–2049. 2008. View Article : Google Scholar
|
|
11
|
Sun W: Angiogenesis in metastatic
colorectal cancer and the benefits of targeted therapy. J Hematol
Oncol. 5:632012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Weis SM and Cheresh DA: Tumor
angiogenesis: molecular pathways and therapeutic targets. Nat Med.
17:1359–1370. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qian WF, Guan WX, Gao Y, Tan JF, Qiao ZM,
Huang H and Xia CL: Inhibition of STAT3 by RNA interference
suppresses angiogenesis in colorectal carcinoma. Braz J Med Biol
Res. 44:1222–1230. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Berra E, Pagès G and Pouysségur J: MAP
kinases and hypoxia in the control of VEGF expression. Cancer
Metastasis Rev. 19:139–145. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stromblad S and Cheresh DA: Integrins,
angiogenesis and vascular cell survival. Chem Biol. 3:881–885.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Breier G and Risau W: The role of vascular
endothelial growth factor in blood vessel formation. Trends Cell
Biol. 6:454–456. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Weidner N, Semple JP, Welch WR and Folkman
J: Tumor angiogenesis and metastasis-correlation in invasive breast
carcinoma. N Engl J Med. 324:1–8. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ferrara N: Role of vascular endothelial
growth factor in physiologic and pathologic angiogenesis:
therapeutic implications. Semin Oncol. 29:10–14. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jain RK: Tumor angiogenesis and
accessibility: role of vascular endothelial growth factor. Semin
Oncol. 29:3–9. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Risau W: Mechanisms of angiogenesis.
Nature. 386:671–674. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ziche M and Morbidelli L: Molecular
regulation of tumour angiogenesis by nitric oxide. Eur Cytokine
Netw. 20:164–170. 2009.PubMed/NCBI
|
|
22
|
Cooke JP and Losordo DW: Nitric oxide and
angiogenesis. Circulation. 105:2133–2135. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Eikesdal HP and Kalluri R: Drug resistance
associated with antiangiogenesis therapy. Semin Cancer Biol.
19:310–317. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Newman DJ, Cragg GM and Snader KM: The
influence of natural products upon drug discovery. Nat Prod Rep.
17:215–234. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gordaliza M: Natural products as leads to
anticancer drugs. Clin Transl Oncol. 9:767–776. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ji HF, Li XJ and Zhang HY: Natural
products and drug discovery. EMBO Rep. 10:194–200. 2009.PubMed/NCBI
|
|
27
|
Chinese Pharmacopoeia Commission.
Pharmacopoeia of the Peoples Republic of China. Chinese Medical
Science and Technology Press; 1. pp. 573–575. 2010
|
|
28
|
Lin JM, Wei LH, Chen YQ, Liu XX, Hong ZF,
Sferra TJ and Peng J: Pien Tze Huang-induced apoptosis in human
colon cancer HT-29 cells is associated with regulation of the Bcl-2
family and activation of caspase 3. Chin J Integr Med. 17:685–690.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhuang QC, Hong F, Shen AL, Zheng LP, Zeng
JW, Lin W, Chen YQ, Sferra TJ, Hong ZF and Peng J: Pien Tze Huang
inhibits tumor cell proliferation and promotes apoptosis via
suppressing the STAT3 pathway in a colorectal cancer mouse model.
Int J Oncol. 40:1569–1574. 2012.PubMed/NCBI
|
|
30
|
Shen AL, Hong F, Liu LY, Lin JM, Zhuang
QC, Hong ZF and Peng J: Effects of Pien Tze Huang on angiogenesis
in vivo and in vitro. Chin J Integr Med. 18:431–436. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shen AL, Hong F, Liu LY, Lin JM, Wei LH,
Cai QY, Hong ZF and Peng J: Pien Tze Huang inhibits the
proliferation of human colon carcinoma cells by arresting G1/S cell
cycle progression. Oncol Lett. 4:767–770. 2012.PubMed/NCBI
|
|
32
|
Shen AL, Chen YQ, Hong F, Lin JM, Wei LH,
Hong ZF, Sferra TJ and Peng J: Pien Tze Huang suppresses
IL-6-inducible STAT3 activation in human colon carcinoma cells
through induction of SOCS3. Oncol Rep. 28:2125–2130.
2012.PubMed/NCBI
|
|
33
|
Kaya M, Wada T, Akatsuka T, Kawaguchi S,
Nagoya S, Shindoh M, Higashino F, Mezawa F, Okada F and Ishii S:
Vascular endothelial growth factor expression in untreated
osteosarcoma is predictive of pulmonary metastasis and poor
prognosis. Clin Cancer Res. 6:572–577. 2000.PubMed/NCBI
|
|
34
|
Maeda K, Chung YS, Ogawa Y, Takatsuka S,
Kang SM, Ogawa M, Sawada T and Sowa M: Prognostic value of vascular
endothelial growth factor expression in gastric carcinoma. Cancer.
77:858–863. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ferrara N, Gerber HP and LeCouter J: The
biology of VEGF and its receptors. Nat Med. 9:669–676. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ishigami SI, Arii S, Furutani M, Niwano M,
Harada T, Mizumoto M, Mori A, Onodera H and Imamura M: Predictive
value of vascular endothelial growth factor (VEGF) in metastasis
and prognosis of human colorectal cancer. Br J Cancer.
78:1379–1384. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gille H, Kowalski J, Li B, LeCouter J,
Moffat B, Zioncheck TF, Pelletier N and Ferrara N: Analysis of
biological effects and signaling properties of Flt-1 (VEGFR-1) and
KDR (VEGFR-2). A reassessment using novel receptor-specific
vascular endothelial growth factor mutants. J Biol Chem.
276:3222–3230. 2001. View Article : Google Scholar
|
|
38
|
Fukumura D, Gohongi T, Kadambi A, Izumi Y,
Ang J, Yun CO, Buerk DG, Huang PL and Jain RK: Predominant role of
endothelial nitric oxide synthase in vascular endothelial growth
factor-induced angiogenesis and vascular permeability. Proc Natl
Acad Sci USA. 98:2604–2609. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sessa WC: eNOS at a glance. J Cell Sci.
117:2427–2429. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Vakkala M, Kahlos K, Lakari E, Paakko P,
Kinnula V and Soini Y: Inducible nitric oxide synthase expression,
apoptosis, and angiogenesis in situ and invasive breast carcinomas.
Clin Cancer Res. 6:2408–2416. 2000.PubMed/NCBI
|
|
41
|
Aaltomaa SH, Lipponen PK and Kosma VM:
Inducible nitric oxide synthase (iNOS) expression and its
prognostic value in prostate cancer. Anticancer Res. 21:3101–3106.
2001.PubMed/NCBI
|
